Related Experiment Videos
Neonatal hypercalcemia.
1University of the País Vasco, Department of Pediatrics, Hospital de Cruces, Bilbao, Vizcaya, Spain. jsoriano@hcru.osakidetza.es
Journal of Nephrology
|December 31, 2003
Summary
Neonatal hypercalcemia diagnosis relies on parathyroid hormone (PTH) levels. Low PTH suggests calcium overload, high PTH indicates hyperparathyroidism due to CaR gene mutations, and normal PTH with hypocalciuria points to familial hypocalciuric hypercalcemia.
Area of Science:
- Pediatric Endocrinology
- Nephrology
- Genetics
Background:
- Neonatal hypercalcemia presents with diverse etiologies.
- Accurate diagnosis is crucial for appropriate management.
- Plasma parathyroid hormone (PTH) levels are a key diagnostic marker.
Purpose of the Study:
- To outline the diagnostic approach to neonatal hypercalcemia based on PTH levels.
- To differentiate between various causes of hypercalcemia in newborns.
- To highlight the significance of urinary calcium excretion in specific conditions.
Main Methods:
- Analysis of plasma parathyroid hormone (PTH) levels.
- Assessment of urinary calcium excretion.
- Correlation of hormonal and excretory findings with clinical presentation.
Main Results:
- Diminished plasma PTH suggests exogenous or endogenous calcium overloading.
- Increased plasma PTH indicates hyperparathyroidism, potentially due to CaR gene mutations.
- Normal plasma PTH with relative hypocalciuria is characteristic of familial hypocalciuric hypercalcemia (FHH).
Conclusions:
- Plasma PTH levels are pivotal in diagnosing neonatal hypercalcemia.
- Distinguishing between calcium overload, primary hyperparathyroidism, and FHH is guided by PTH and calcium excretion patterns.
- Genetic factors, such as CaR gene mutations, play a role in certain forms of neonatal hypercalcemia.